BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15343516)

  • 1. The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas.
    Ahmad N; Keehn CA; Coppola D
    Hum Pathol; 2004 Sep; 35(9):1132-6. PubMed ID: 15343516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
    Sichani MM; Yazdi FS; Moghaddam NA; Chehrei A; Kabiri M; Naeimi A; Taheri D
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):69-74. PubMed ID: 20061696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.
    Schips L; Zigeuner R; Ratschek M; Rehak P; Rüschoff J; Langner C
    Am J Clin Pathol; 2004 Dec; 122(6):931-7. PubMed ID: 15539386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.
    Parker A; Cheville JC; Lohse C; Cerhan JR; Blute ML
    J Urol; 2003 Aug; 170(2 Pt 1):420-4. PubMed ID: 12853790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.
    Parker AS; Cheville JC; Janney CA; Cerhan JR
    Hum Pathol; 2002 Aug; 33(8):801-5. PubMed ID: 12203212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation].
    Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Mazzucchelli R; Milanese G; Natali D; Galosi AB; Montironi R; Biagini G; Muzzonigro G
    J Urol; 2005 Oct; 174(4 Pt 1):1208-12. PubMed ID: 16145371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.
    Wang L; Hu H; Tian F; Zhou W; Zhou S; Wang J
    Int J Clin Exp Pathol; 2015; 8(10):13374-80. PubMed ID: 26722543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic ability of simplified nuclear grading of renal cell carcinoma.
    Rioux-Leclercq N; Karakiewicz PI; Trinh QD; Ficarra V; Cindolo L; de la Taille A; Tostain J; Zigeuner R; Mejean A; Patard JJ
    Cancer; 2007 Mar; 109(5):868-74. PubMed ID: 17262800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor expression in clear cell renal cell carcinoma and its relation to prognosis.
    Lkhagvadorj S; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M
    Yonsei Med J; 2014 Jul; 55(4):861-70. PubMed ID: 24954312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
    Rosendahl A; Forsberg G
    Int J Oncol; 2004 Nov; 25(5):1327-36. PubMed ID: 15492822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Expression of Emerin in Renal Cell Carcinomas: Does It Contribute to Histopathological Features and WHO/ISUP Grading in Predicting Prognosis?
    Argon A; Dal G; Salman T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):89-98. PubMed ID: 33822520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of IGF-IEc Isoform in Renal Cell Carcinoma Tissues.
    Michalopoulou F; Petraki C; Philippou A; Analitis A; Msaouel P; Koutsilieris M
    Anticancer Res; 2020 Nov; 40(11):6213-6219. PubMed ID: 33109558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.